In Q1 FY2026, Evolent Health reported revenue of $496.2 million, up 2.6% year-over-year. Net loss narrowed to $26.6 million from $64.6 million a year ago, a 58.8% improvement. Operating income was negative $10.6 million, compared to positive $2.3 million in Q1 FY2025. Diluted EPS was -$0.24, improving from -$0.63 in the prior year quarter.
•Revenue increased 2.6% YoY to $496.2 million.
•Net loss improved 58.8% to $26.6 million.
•Operating income swung to a loss of $10.6 million from a gain of $2.3 million.
•Diluted EPS improved to -$0.24 from -$0.63.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Evolent Health, Inc., through its subsidiary provides specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company offers integrated value-based care platform for health plan administration and management, as well as administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management
Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. Additionally, it provides Machinify Auth Intelligence, an artificial intelligence tool to aid nurses and physicians in completing clinical review of prior authorization requests. Founded in 2011, Evolent Health is headquartered in Arlington, Virginia.
Evolent Health, Inc., through its subsidiary, provides specialty care management services in the oncology, cardiology, and musculoskeletal markets across the United States. The company offers an integrated value-based care platform for health plan administration and management, which includes services such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management. Additionally, Evolent Health provides Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The company also offers Machinify Auth Intelligence, an artificial intelligence tool designed to assist nurses and physicians in completing clinical reviews of prior authorization requests.
Where is Evolent Health (EVH) listed and in what currency?
Evolent Health is publicly traded on the New York Stock Exchange (NYSE) under the ticker symbol EVH. The company's financials are reported in US Dollars (USD), reflecting its operations based in the United States. As a US-listed company, its stock is traded in USD, and investors typically use US dollars to buy and sell shares on the NYSE.
What sector and industry does Evolent Health (EVH) operate in?
Evolent Health operates in the Healthcare sector, specifically within the Health Information Services industry. This industry focuses on providing technology-driven solutions and services that improve healthcare delivery, manage patient data, and support value-based care models. Evolent Health's offerings, such as its Identifi platform and Machinify Auth Intelligence tool, align with this industry by leveraging data analytics and artificial intelligence to enhance care management and administrative processes for health plans and providers.
Where is Evolent Health (EVH) headquartered and what markets does it serve?
Evolent Health is headquartered in Arlington, Virginia, United States. The company was founded in 2011 and primarily serves the US healthcare market. Its specialty care management services focus on three key areas: oncology, cardiology, and musculoskeletal markets. By operating within the United States, Evolent Health partners with health plans and providers to deliver value-based care solutions that aim to improve patient outcomes and reduce costs across these therapeutic areas.
How does Evolent Health (EVH) make money?
Evolent Health generates revenue by offering an integrated value-based care platform and administrative services to health plans and providers. The company's core offerings include health plan administration, pharmacy benefits management, risk management, analytics and reporting, and leadership and management services. Additionally, Evolent Health provides Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. The company also offers Machinify Auth Intelligence, an AI tool that streamlines clinical review of prior authorization requests. By helping clients transition to value-based care models, Evolent Health earns fees based on the services provided and potentially shares in cost savings achieved.